Ha J
Biomedicines. 2025; 13(1.
PMID: 39857720
PMC: 11762804.
DOI: 10.3390/biomedicines13010136.
Guo S, Mao C, Peng J, Xie S, Yang J, Xie W
Heliyon. 2024; 10(4):e26081.
PMID: 38384512
PMC: 10878959.
DOI: 10.1016/j.heliyon.2024.e26081.
Yang M, Hu X, Tang B, Deng F
Heliyon. 2024; 10(2):e24811.
PMID: 38312618
PMC: 10835372.
DOI: 10.1016/j.heliyon.2024.e24811.
El-Din S, Rashed L, Saeed Mohamed D, Eissa M, Hamed R, Elsayed Hussein R
Rep Biochem Mol Biol. 2023; 12(1):195-204.
PMID: 37724157
PMC: 10505462.
DOI: 10.52547/rbmb.12.1.195.
Holme J, Vondracek J, Machala M, Lagadic-Gossmann D, Vogel C, Le Ferrec E
Biochem Pharmacol. 2023; 216:115801.
PMID: 37696458
PMC: 10543654.
DOI: 10.1016/j.bcp.2023.115801.
Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients.
Raczkowska J, Bielska A, Kretowski A, Niemira M
Front Oncol. 2023; 13:1209299.
PMID: 37546401
PMC: 10401434.
DOI: 10.3389/fonc.2023.1209299.
Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?.
Robotti M, Scebba F, Angeloni D
Biomedicines. 2023; 11(3).
PMID: 36979630
PMC: 10044752.
DOI: 10.3390/biomedicines11030652.
Bioinformatics analysis of miRNA and its associated genes to identify potential biomarkers of oral submucous fibrosis and oral malignancy.
Mohanan E, Jhala D, More C, Patel A, Joshi C
Cancer Rep (Hoboken). 2023; 6(4):e1787.
PMID: 36708238
PMC: 10075298.
DOI: 10.1002/cnr2.1787.
Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC - A systematic review.
Samarth N, Gulhane P, Singh S
Front Oncol. 2023; 12:1089320.
PMID: 36620544
PMC: 9811680.
DOI: 10.3389/fonc.2022.1089320.
miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response.
Cuttano R, Colangelo T, Guarize J, Dama E, Cocomazzi M, Mazzarelli F
J Hematol Oncol. 2022; 15(1):178.
PMID: 36587234
PMC: 9805174.
DOI: 10.1186/s13045-022-01394-1.
Tumor Suppressor miRNA-503 Inhibits Cell Invasion in Head and Neck Cancer through the Wnt Signaling Pathway via the WNT3A/MMP Molecular Axis.
Tang S, Fan K, You G, Huang S, Kang C, Huang Y
Int J Mol Sci. 2022; 23(24).
PMID: 36555553
PMC: 9786678.
DOI: 10.3390/ijms232415900.
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.
Fariha A, Hami I, Tonmoy M, Akter S, Al Reza H, Bahadur N
Heliyon. 2022; 8(10):e11081.
PMID: 36303933
PMC: 9593298.
DOI: 10.1016/j.heliyon.2022.e11081.
Exploring histopathological and serum biomarkers in lung adenocarcinoma: Clinical applications and translational opportunities (Review).
Ortega M, Navarro F, Pekarek L, Fraile-Martinez O, Garcia-Montero C, Saez M
Int J Oncol. 2022; 61(6).
PMID: 36263628
PMC: 9635864.
DOI: 10.3892/ijo.2022.5444.
Advances on Innate Immune Evasion by Avian Immunosuppressive Viruses.
Wang H, Li W, Zheng S
Front Immunol. 2022; 13:901913.
PMID: 35634318
PMC: 9133627.
DOI: 10.3389/fimmu.2022.901913.
Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications.
Wong K, Cheung A, Chen B, Chan W, Yu J, Lo K
Int J Cancer. 2022; 151(8):1195-1215.
PMID: 35603909
PMC: 9545594.
DOI: 10.1002/ijc.34127.
MicroRNA-155-5p modulates the progression of acute respiratory distress syndrome by targeting interleukin receptors.
Huang Z, Huang H, Shen M, Li C, Liu C, Zhu H
Bioengineered. 2022; 13(5):11732-11741.
PMID: 35506298
PMC: 9276023.
DOI: 10.1080/21655979.2022.2071020.
The role of microRNAs in COVID-19 with a focus on miR-200c.
Sodagar H, Alipour S, Hassani S, Gholizadeh-Ghaleh Aziz S, Khadem Ansari M, Asghari R
J Circ Biomark. 2022; 11:14-23.
PMID: 35356072
PMC: 8939267.
DOI: 10.33393/jcb.2022.2356.
Prognostic value of let-7 in lung cancer: systematic review and meta-analysis.
Shen C, Li J, Che G
Transl Cancer Res. 2022; 9(10):6354-6361.
PMID: 35117243
PMC: 8799185.
DOI: 10.21037/tcr-20-1240.
Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review.
Md S, Alhakamy N, Karim S, Gabr G, Iqubal M, Murshid S
Pharmaceutics. 2021; 13(12).
PMID: 34959401
PMC: 8708027.
DOI: 10.3390/pharmaceutics13122120.
Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review.
Gholami L, Ivari J, Nasab N, Kazemi Oskuee R, Sathyapalan T, Sahebkar A
Curr Med Chem. 2021; 30(3):335-355.
PMID: 34375182
DOI: 10.2174/0929867328666210810160901.